Know Cancer

or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Study of Late-Occurring Complications in Childhood Cancer Survivors
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Neuroblastoma
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Leukemia
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Ann Arbor, Michigan 48106
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Bladder Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Leukemia
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    University of Michigan Health System (Adult Site)
    Ann Arbor, Michigan 48109
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    University of Michigan University Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lymphoma
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Brain and Central Nervous System Tumors
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Metastatic Cancer, Prostate Cancer
    Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Bladder Cancer
    Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
    The University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans
    Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
    The University of Michigan
    Ann Arbor, Michigan 48109
    Graft-Versus-Host Disease
    Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
    The University of Michigan
    Ann Arbor, Michigan 48109
    Wilms Tumor, Fibrosarcoma, Carcinoma, Round Cell, Nasopharyngeal Cancer, Brain Tumor, Recurrent
    Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
    The University of Michigan
    Ann Arbor, Michigan 48109
    Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade
    Tetrathiomolybdate in Hormone Refractory Prostate Cancer
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Prostate Cancer
    Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Urologic Neoplasms
    Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Prostate Cancer
    Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
    The University of Michigan Comprehensive Cancer
    Ann Arbor, Michigan
    Prostate Cancer
    Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Hormone-Refractory Prostate Cancer
    Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Prostate Cancer
    Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Multiple Myeloma
    Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Metastatic Breast Cancer
    Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Esophageal Carcinoma
    Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Sarcoma, Soft Tissue
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Aromatase Inhibitor Clinical Trial
    UMCCC
    Ann Arbor, Michigan 48109
    Breast Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Bladder Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Fallopian Tube Cancer, Ovarian Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Ann Arbor, Michigan 48109
    Non-Hodgkin's Lymphoma
    N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Neuroblastoma
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer